Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Control mice were injected with aqueous vaccine using a 26.5-gauge needle. The subcutaneous injection was given in the scruff of the neck and the intramuscular injection was made in the upper thigh.

The LifeSite subcutaneous access ... antibiotic prophylaxis. This injection of 70% IPA is performed before and after each dialysis session. Because the 25-gauge needle does not open the internal ...

In June 2024, Vyvgart Hytrulo was approved in a once-weekly, 30- to 90-second subcutaneous injection for adults with CIDP.

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Patient adherence and persistence with injection-based chronic therapy regimes are notoriously low owing to, among other factors, needle anxiety ... to reach the desired subcutaneous space ...